Epidural Waveform Analysis for Epidurals
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of a new method called epidural waveform analysis (EWA) compared to the usual X-ray method for placing epidurals. EWA checks the pressure in the epidural space to confirm correct placement by identifying a specific heart rate pattern. People undergoing surgery and planning to receive a thoracic epidural at Dartmouth Hitchcock Medical Center may qualify for this study. The trial seeks to determine if EWA is as reliable as the traditional method currently in use. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could enhance epidural placement techniques.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that epidural waveform analysis is safe for confirming epidural placement?
Research has shown that epidural waveform analysis (EWA) safely confirms correct epidural placement. Studies have found EWA to be a simple and low-cost method for checking epidural placement. EWA uses the same pressure measuring tools already employed for other purposes, such as checking blood pressure or brain pressure, ensuring the equipment is well-tested and safe.
Previous findings suggest that EWA results in fewer complications than traditional methods. Specifically, one study found the failure rate for epidural blocks was much lower with EWA, at just 2%, compared to 24% with the conventional method. This indicates that EWA is not only safe but also more effective in ensuring correct epidural placement, reducing the chance of complications. Overall, EWA is considered well-tolerated and carries a low risk of side effects.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new method, Epidural Waveform Analysis (EWA), to confirm epidural access. Unlike the standard fluoroscopic confirmation, which uses X-rays to visualize the epidural space, EWA analyzes the waveform patterns of pressure changes. This approach could potentially offer a non-invasive, radiation-free alternative for confirming epidural placement. If successful, it may lead to safer and more accessible epidural procedures, reducing the need for fluoroscopy.
What evidence suggests that epidural waveform analysis is effective for confirming epidural placement?
Research has shown that epidural waveform analysis (EWA) can effectively confirm correct epidural placement. One study found that EWA accurately identifies correct placement, while another study highlighted EWA as a simple and low-cost method for checking epidural location. This trial will compare the accuracy of EWA to the gold standard of fluoroscopic confirmation (FC). The researchers hypothesize that FC is superior to EWA. However, EWA might not detect incorrect placements if pain relief is inadequate. Overall, early evidence supports EWA as a promising tool for confirming epidural access.12678
Who Is on the Research Team?
Alexander Abess, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
Are You a Good Fit for This Trial?
This trial is for individuals who require an epidural, a type of anesthesia that blocks pain in a particular region of the body. Participants must be suitable candidates for both EWA and fluoroscopic guidance procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo both epidural waveform analysis and fluoroscopic confirmation for epidural placement
Follow-up
Participants are monitored for safety and effectiveness after the procedure
What Are the Treatments Tested in This Trial?
Interventions
- Epidural Waveform Analysis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor